Abstract
Although the concept of nephrotoxicity has been recognized for more than 80 years, interest in nephrotoxins has intensified dramatically over the past two decades. Much of this attention has rightfully been focused on pharmaceutical agents and iatrogenic harm; however, it is important for providers to recognize that nephrotoxins can be found in naturally occurring substances as well. Although nephrotoxins exist in a myriad of forms, the means by which they induce injury can be organized into a few categories. For most of these agents, regardless of the mechanism, the final common pathway is acute kidney injury (AKI). Unfortunately, therapeutic options are limited and no treatments currently exist to reverse nephrotoxic AKI once it occurs. As a result, current strategies focus on increased awareness, nephrotoxin avoidance, early injury detection, and mitigation of disease severity. The goal of this review is to summarize our current understanding of nephrotoxic mechanisms and the epidemiology of nephrotoxic AKI. Additionally, avoidance and preventative strategies are discussed, screening approaches are suggested, and chronic monitoring recommendations are made.
Similar content being viewed by others
References
Schreiner GE (1965) Toxic nephropathy: adverse renal effects caused by drugs and chemicals. JAMA 191:849–850
Balter P, Muehrcke RC, Morris AM, Moles JB, Lawrence AG (1976) Chronic toxic nephropathies--diagnosis and management. Ann Clin Lab Sci 6:306–311
Kleinknecht D, Landais P, Goldfarb B (1987) Drug-associated acute renal failure. A prospective collaborative study of 81 biopsied patients. Adv Exp Med Biol 212:125–128
Kleinknecht D, Landais P, Goldfarb B (1986) Analgesic and non-steroidal anti-inflammatory drug-associated acute renal failure: a prospective collaborative study. Clin Nephrol 25:275–281
Thomas MC (2000) Diuretics, ACE inhibitors and NSAIDs--the triple whammy. Med J Aust 172:184–185
Moffett BS, Goldstein SL (2011) Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol 6:856–863. https://doi.org/10.2215/CJN.08110910
Schetz M, Dasta J, Goldstein S, Golper T (2005) Drug-induced acute kidney injury. Curr Opin Crit Care 11:555–565
Gupta N, Gibson M, Wallace EC (2019) Lithium-induced chronic kidney disease in a pediatric patient. Case Rep Pediatr 2019:5406482. https://doi.org/10.1155/2019/5406482
Markowitz GS, Radhakrishnan J, Kambham N, Valeri AM, Hines WH, D’Agati VD (2000) Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 11:1439–1448
Pape L, Ahlenstiel T (2014) mTOR inhibitors in pediatric kidney transplantation. Pediatr Nephrol 29:1119–1129. https://doi.org/10.1007/s00467-013-2505-9
KDIGO AKI Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1–138
Abuelo JG (1990) Renal failure caused by chemicals, foods, plants, animal venoms, and misuse of drugs. An overview. Arch Intern Med 150:505–510
Neto MM, Silva GEB, Costa RS, Vieira Neto OM, Garcia-Cairasco N, Lopes NP, Haendchen PFC, Silveira C, Mendes AR, Filho RR, Dantas M (2009) Star fruit: simultaneous neurotoxic and nephrotoxic effects in people with previously normal renal function. NDT Plus 2:485–488. https://doi.org/10.1093/ndtplus/sfp108
Soderland P, Lovekar S, Weiner DE, Brooks DR, Kaufman JS (2010) Chronic kidney disease associated with environmental toxins and exposures. Adv Chronic Kidney Dis 17:254–264. https://doi.org/10.1053/j.ackd.2010.03.011
Nanavati A, Herlitz LC (2017) Tubulointerstitial injury and drugs of abuse. Adv Chronic Kidney Dis 24:80–85. https://doi.org/10.1053/j.ackd.2016.09.008
Goldstein SL, Kirkendall E, Nguyen H, Schaffzin JK, Bucuvalas J, Bracke T, Seid M, Ashby M, Foertmeyer N, Brunner L, Lesko A, Barclay C, Lannon C, Muething S (2013) Electronic health record identification of nephrotoxin exposure and associated acute kidney injury. Pediatrics 132:e756–e767. https://doi.org/10.1542/peds.2013-0794
Basu RK, Kaddourah A, Terrell T, Mottes T, Arnold P, Jacobs J, Andringa J, Goldstein SL, Prospective Pediatric AKI Research Group (ppAKI) (2015) Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study. BMC Nephrol 16:24. https://doi.org/10.1186/s12882-015-0016-6
Hoste EAJ, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honoré PM, Joannes-Boyau O, Joannidis M, Korhonen A-M, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41:1411–1423. https://doi.org/10.1007/s00134-015-3934-7
McGregor TL, Jones DP, Wang L, Danciu I, Bridges BC, Fleming GM, Shirey-Rice J, Chen L, Byrne DW, Van Driest SL (2016) Acute kidney injury incidence in noncritically ill hospitalized children, Adolescents, and young adults: a retrospective observational study. Am J Kidney Dis 67:384–390. https://doi.org/10.1053/j.ajkd.2015.07.019
Goldstein SL (2017) Nephrotoxicities. F1000Res 6:55. https://doi.org/10.12688/f1000research.10192.1
Hui-Stickle S, Brewer ED, Goldstein SL (2005) Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 45:96–101
McWilliam SJ, Antoine DJ, Smyth RL, Pirmohamed M (2017) Aminoglycoside-induced nephrotoxicity in children. Pediatr Nephrol 32:2015–2025. https://doi.org/10.1007/s00467-016-3533-z
Hazlewood KA, Brouse SD, Pitcher WD, Hall RG (2010) Vancomycin-associated nephrotoxicity: grave concern or death by character assassination? Am J Med 123:182.e1–182.e7. https://doi.org/10.1016/j.amjmed.2009.05.031
Moffett BS, Morris J, Kam C, Galati M, Dutta A, Akcan-Arikan A (2018) Vancomycin associated acute kidney injury in pediatric patients. PLoS One 13:e0202439. https://doi.org/10.1371/journal.pone.0202439
Moffett BS, Hilvers PS, Dinh K, Arikan AA, Checchia P, Bronicki R (2015) Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients. Congenit Heart Dis 10:E6–E10. https://doi.org/10.1111/chd.12187
Hays WB, Tillman E (2019) Vancomycin-associated acute kidney injury in critically ill adolescent and young adult patients. J Pharm Pract. https://doi.org/10.1177/0897190019829652
Do C (2017) Intravenous contrast: friend or foe? A review on contrast-induced nephropathy. Adv Chronic Kidney Dis 24:147–149. https://doi.org/10.1053/j.ackd.2017.03.003
Luk L, Steinman J, Newhouse JH (2017) Intravenous contrast-induced nephropathy-the rise and fall of a threatening idea. Adv Chronic Kidney Dis 24:169–175. https://doi.org/10.1053/j.ackd.2017.03.001
Wilhelm-Leen E, Montez-Rath ME, Chertow G (2017) Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol 28:653–659. https://doi.org/10.1681/ASN.2016010021
Davenport MS, Khalatbari S, Cohan RH, Dillman JR, Myles JD, Ellis JH (2013) Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. Radiology 268:719–728. https://doi.org/10.1148/radiol.13122276
McDonald RJ, McDonald JS, Carter RE, Hartman RP, Katzberg RW, Kallmes DF, Williamson EE (2014) Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. Radiology 273:714–725. https://doi.org/10.1148/radiol.14132418
Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL, Investigators AWARE (2017) Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med 376:11–20. https://doi.org/10.1056/NEJMoa1611391
Zappitelli M, Moffett BS, Hyder A, Goldstein SL (2011) Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study. Nephrol Dial Transplant 26:144–150. https://doi.org/10.1093/ndt/gfq375
Sutherland SM, Ji J, Sheikhi FH, Widen E, Tian L, Alexander SR, Ling XB (2013) AKI in hospitalized children: epidemiology and clinical associations in a national cohort. Clin J Am Soc Nephrol 8:1661–1669. https://doi.org/10.2215/CJN.00270113
Askenazi DJ, Feig DI, Graham NM, Hui-Stickle S, Goldstein SL (2006) 3-5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int 69:184–189. https://doi.org/10.1038/sj.ki.5000032
Mammen C, Al Abbas A, Skippen P, Nadel H, Levine D, Collet JP, Matsell DG (2012) Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. Am J Kidney Dis 59:523–530. https://doi.org/10.1053/j.ajkd.2011.10.048
Goldstein SL, Devarajan P (2008) Progression from acute kidney injury to chronic kidney disease: a pediatric perspective. Adv Chronic Kidney Dis 15:278–283. https://doi.org/10.1053/j.ackd.2008.04.007
Uber AM, Sutherland SM (2018) Acute kidney injury in hospitalized children: consequences and outcomes. Pediatr Nephrol. https://doi.org/10.1007/s00467-018-4128-7
Uber AM, Montez-Rath ME, Kwiatkowski DM, Krawczeski CD, Sutherland SM (2018) Nephrotoxin exposure and acute kidney injury in critically ill children undergoing congenital cardiac surgery. Pediatr Nephrol 33:2193–2199. https://doi.org/10.1007/s00467-018-4010-7
Hayes W (2017) Stop adding insult to injury-identifying and managing risk factors for the progression of acute kidney injury in children. Pediatr Nephrol 32:2235–2243. https://doi.org/10.1007/s00467-017-3598-3
Xu X, Nie S, Zhang A, Mao J, Liu H-P, Xia H, Xu H, Liu Z, Feng S, Zhou W, Liu X, Yang Y, Tao Y, Feng Y, Chen C, Wang M, Zha Y, Feng J-H, Li Q, Ge S, Chen J, He Y, Teng S, Hao C, Liu B-C, Tang Y, He W, He P, Hou FF (2018) Acute kidney injury among hospitalized children in China. Clin J Am Soc Nephrol 13:1791–1800. https://doi.org/10.2215/CJN.00800118
Menon S, Kirkendall ES, Nguyen H, Goldstein SL (2014) Acute kidney injury associated with high nephrotoxic medication exposure leads to chronic kidney disease after 6 months. J Pediatr 165:522–527.e2. https://doi.org/10.1016/j.jpeds.2014.04.058
Jones DP, Spunt SL, Green D, Springate JE, Children’s Oncology Group (2008) Renal late effects in patients treated for cancer in childhood: a report from the Children’s Oncology Group. Pediatr Blood Cancer 51:724–731. https://doi.org/10.1002/pbc.21695
Hanna MH, Askenazi DJ, Selewski DT (2016) Drug-induced acute kidney injury in neonates. Curr Opin Pediatr 28:180–187. https://doi.org/10.1097/MOP.0000000000000311
Goldstein SL, Mottes T, Simpson K, Barclay C, Muething S, Haslam DB, Kirkendall ES (2016) A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int 90:212–221. https://doi.org/10.1016/j.kint.2016.03.031
Greenberg JH, Parikh CR (2017) Biomarkers for diagnosis and prognosis of AKI in children: one size does not fit all. Clin J Am Soc Nephrol 12:1551–1557. https://doi.org/10.2215/CJN.12851216
Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, Bittleman D, Cruz D, Endre Z, Fitzgerald RL, Forni L, Kane-Gill SL, Hoste E, Koyner J, Liu KD, Macedo E, Mehta R, Murray P, Nadim M, Ostermann M, Palevsky PM, Pannu N, Rosner M, Wald R, Zarbock A, Ronco C, Kellum JA, Acute Disease Quality Initiative Workgroup 16 (2017) Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol 13:241–257. https://doi.org/10.1038/nrneph.2017.2
Sutherland SM (2018) Electronic health record-enabled big-data approaches to nephrotoxin-associated acute kidney injury risk prediction. Pharmacotherapy 38:804–812. https://doi.org/10.1002/phar.2150
Crona DJ, Faso A, Nishijima TF, McGraw KA, Galsky MD, Milowsky MI (2017) A systematic review of strategies to prevent cisplatin-induced nephrotoxicity. Oncologist 22:609–619. https://doi.org/10.1634/theoncologist.2016-0319
Izzedine H, Launay-Vacher V, Deray G (2005) Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 45:804–817. https://doi.org/10.1053/j.ajkd.2005.02.010
Karimzadeh I, Farsaei S, Khalili H, Dashti-Khavidaki S (2012) Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity? Expert Opin Drug Saf 11:969–983. https://doi.org/10.1517/14740338.2012.721775
Askenazi DJ, Koralkar R, Hundley HE, Montesanti A, Patil N, Ambalavanan N (2013) Fluid overload and mortality are associated with acute kidney injury in sick near-term/term neonate. Pediatr Nephrol 28:661–666. https://doi.org/10.1007/s00467-012-2369-4
Sutherland SM, Zappitelli M, Alexander SR, Chua AN, Brophy PD, Bunchman TE, Hackbarth R, Somers MJG, Baum M, Symons JM, Flores FX, Benfield M, Askenazi D, Chand D, Fortenberry JD, Mahan JD, McBryde K, Blowey D, Goldstein SL (2010) Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 55:316–325. https://doi.org/10.1053/j.ajkd.2009.10.048
Muttath A, Annayappa Venkatesh L, Jose J, Vasudevan A, Ghosh S (2019) Adverse outcomes due to aggressive fluid resuscitation in children: a prospective observational study. J Pediatr Intensive Care 8:64–70. https://doi.org/10.1055/s-0038-1667009
McMahon K, Zappitelli M (2016) Aminophylline for acute kidney injury after pediatric cardiac surgery: finally entering the next phase in child acute kidney injury research. Pediatr Crit Care Med 17:170–171. https://doi.org/10.1097/PCC.0000000000000631
Bhatt GC, Gogia P, Bitzan M, Das RR (2019) Theophylline and aminophylline for prevention of acute kidney injury in neonates and children: a systematic review. Arch Dis Child 104:670–679. https://doi.org/10.1136/archdischild-2018-315805
Axelrod DM, Anglemyer AT, Sherman-Levine SF, Zhu A, Grimm PC, Roth SJ, Sutherland SM (2014) Initial experience using aminophylline to improve renal dysfunction in the pediatric cardiovascular ICU. Pediatr Crit Care Med 15:21–27. https://doi.org/10.1097/01.pcc.0000436473.12082.2f
McLaughlin GE, Abitbol CL (2005) Reversal of oliguric tacrolimus nephrotoxicity in children. Nephrol Dial Transplant 20:1471–1475. https://doi.org/10.1093/ndt/gfh785
Su X, Xie X, Liu L, Lv J, Song F, Perkovic V, Zhang H (2017) Comparative effectiveness of 12 treatment strategies for preventing contrast-induced acute kidney injury: a systematic review and Bayesian Network meta-analysis. Am J Kidney Dis 69:69–77. https://doi.org/10.1053/j.ajkd.2016.07.033
Solomon RJ (2014) Antioxidant therapy with N-acetylcysteine for contrast-induced acute kidney injury: a final nail in the coffin? Coron Artery Dis 25:94–95. https://doi.org/10.1097/MCA.0000000000000076
Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin S-S, Conner TA, Chertow GM, Bhatt DL, Shunk K, Parikh CR, EO MF, Brophy M, Ferguson R, Wu H, Androsenko M, Myles J, Kaufman J, Palevsky PM, PRESERVE Trial Group (2018) Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med 378:603–614. https://doi.org/10.1056/NEJMoa1710933
Shimizu MHM, Gois PHF, Volpini RA, Canale D, Luchi WM, Froeder L, Heilberg IP, Seguro AC (2017) N-acetylcysteine protects against star fruit-induced acute kidney injury. Ren Fail 39:193–202. https://doi.org/10.1080/0886022X.2016.1256315
Huang S, You J, Wang K, Li Y, Zhang Y, Wei H, Liang X, Liu Y (2019) N-acetylcysteine attenuates cisplatin-induced acute kidney injury by inhibiting the C5a receptor. Biomed Res Int 2019:4805853. https://doi.org/10.1155/2019/4805853
Amini S, Robabi HN, Tashnizi MA, Vakili V (2018) Selenium, vitamin C and N-acetylcysteine do not reduce the risk of acute kidney injury after off-pump CABG: a randomized clinical trial. Braz J Cardiovasc Surg 33:129–134. https://doi.org/10.21470/1678-9741-2017-0071
He G, Li Q, Li W, Wang L, Yang J, Zeng F (2018) N-acetylcysteine for preventing of acute kidney injury in chronic kidney disease patients undergoing cardiac surgery: a metaanalysis. Heart Surg Forum 21:E513–E521. https://doi.org/10.1532/hsf.2193
Leino K, Hynynen M, Jalonen J, Salmenperä M, Scheinin H, Aantaa R, Dexmedetomidine in Cardiac Surgery Study Group (2011) Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study. BMC Anesthesiol 11:9. https://doi.org/10.1186/1471-2253-11-9
Ji F, Li Z, Young JN, Yeranossian A, Liu H (2013) Post-bypass dexmedetomidine use and postoperative acute kidney injury in patients undergoing cardiac surgery with cardiopulmonary bypass. PLoS One 8:e77446. https://doi.org/10.1371/journal.pone.0077446
Balkanay OO, Goksedef D, Omeroglu SN, Ipek G (2015) The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study. Interact Cardiovasc Thorac Surg 20:209–214. https://doi.org/10.1093/icvts/ivu367
Kwiatkowski DM, Axelrod DM, Sutherland SM, Tesoro TM, Krawczeski CD (2016) Dexmedetomidine is associated with lower incidence of acute kidney injury after congenital heart surgery. Pediatr Crit Care Med 17:128–134. https://doi.org/10.1097/PCC.0000000000000611
Benoit SW, Goldstein SL, Dahale DS, Haslam DB, Nelson A, Truono K, Davies SM (2019) Reduction in nephrotoxic antimicrobial exposure decreases associated acute kidney injury in pediatric hematopoietic stem cell transplant patients. Biol Blood Marrow Transplant 25:1654–1658. https://doi.org/10.1016/j.bbmt.2019.04.022
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Uber, A.M., Sutherland, S.M. Nephrotoxins and nephrotoxic acute kidney injury. Pediatr Nephrol 35, 1825–1833 (2020). https://doi.org/10.1007/s00467-019-04397-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-019-04397-2